Cytonus Therapeutics
↗Carlsbad, California, United States
Cytonus Therapeutics is a San Diego/Carlsbad-based biotechnology company developing innovative cell-based therapeutics using its proprietary Cargocyte™ platform. Cargocytes are engineered, enucleated synthetic cells designed to act as biological delivery vehicles, safely transporting therapeutic payloads to disease-specific tissues within hours of intravenous administration. The company combines AI-driven drug discovery with synthetic biology to create immunotherapeutic medicines addressing multiple therapeutic areas including oncology, infectious diseases, inflammatory diseases, and cognitive disorders. The company was spun out from UC San Diego in 2018 by CEO Remo Moomiaie-Qajar and co-founder Richard Klemke, leveraging cutting-edge research to translate cellular engineering into clinical therapies.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Cellular immunotherapy and drug delivery
SIZE & FINANCIALS
Employees:51-200
Founded:2018
Ownership:private
Status:operating
FUNDING
Stage:Series A
Total Raised:$14.4M
Investors:Partners Investment (lead), John Ballantyne, PhD (individual investor), Proxima VC, Gemseki Fund, KreaMedica, WSGR Fund, Creative Ventures
PIPELINE
Stage:Phase 1
Lead Drug Stage:Phase 1
Modalities:Cell therapy, Synthetic biology, Engineered cell delivery, Immunotherapy, Oncolytic virus, Cytokine therapy
Active Trials:1
Trial Phases:Phase 1: 1
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:UC San Diego (technology origin, continued research collaboration), Medinno Inc. (HIEstem™ licensing agreement for North America and MENA), Trauma Insight (partnership announced April 2020)
COMPETITION
Position:Emerging
Competitors:Moderna, Jazz Pharmaceuticals, BeiGene, Targazyme, Revitope Oncology, Cybrexa Therapeutics, CytoImmune Therapeutics
LEADERSHIP
Key Executives:
Remo Moomiaie-Qajar, PhD - Chief Executive Officer & Co-Founder
Richard Klemke, PhD - Co-Founder & Chief Scientific Officer
Mickey Kim, MD, MBA - Chief Business Officer
Karen Markham - Chief Administrative Officer
Sherry M. Carty, PhD - Director of Intellectual Property
Michael Houston, PhD - Scientific Advisory Board Member
Scientific Founders:Remo Moomiaie-Qajar, PhD (CEO, Co-Founder), Richard Klemke, PhD (CSO, Co-Founder)
Board Members:Jaeyeol (Jae) An, PhD (Managing Director, Partners Investment Healthcare & Life Sciences Fund - appointed during Series A)
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Cytonus Therapeutics. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.